Validation of a Computational Histology Artificial Intelligence–based Biomarker for BCG Treatment in Non–muscle-invasive Bladder Cancer in the ANZUP 1301 Randomized Phase 3 Trial

European Urology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles